TsGRM Genetiko PAO EBITDA

Que fait TsGRM Genetiko PAO ? TsGRM Genetiko PAO is a Russian company headquartered in Moscow, operating in the medical services sector. The company went public on April 25, 2023, with the ticker GECO.ME and ISIN RU000A105BN4. TsGRM Genetiko PAO provides medical genetic services through its laboratory and production complexes, focusing on genetic diagnostics for hereditary diseases and reproductive disorders. The company operates four specialized laboratories: an Next-Generation Sequencing (NGS) laboratory, a Non-Invasive Prenatal Testing (NIPT) laboratory, an Oncogenetics laboratory, and a Genotyping laboratory. These facilities support comprehensive genetic testing for both healthcare professionals and patients. The company's website is https://genetico.ru/, where further information about its services can be found. TsGRM Genetiko PAO is engaged in the provision of medical services, with no specific industry or sector classification provided. The company's IPO date marks its entry into the public market, reflecting its operational scale and market presence in the Russian healthcare landscape. The firm's structure emphasizes specialized genetic diagnostics, offering services that cater to a range of medical needs, from prenatal care to oncology. TsGRM Genetiko PAO's focus on genetic testing aligns with growing demand for personalized medical solutions in Russia. The company's operations are based in Moscow, leveraging the city's infrastructure and resources for its laboratory services. No additional details about the company's founding year, key personnel, or financial figures are provided in the available information. The company's primary activities involve conducting genetic diagnostics and providing related medical services to both medical practitioners and individual patients. TsGRM Genetiko PAO est l'une des entreprises les plus populaires sur Eulerpool.